Search…

Lates News

15/07/2026

The concept of innovative drugs is gaining momentum, with Zhongsheng Pharmaceutical Industry hitting the limit up, and more than ten stocks including Dize Pharmaceutical, Borui Pharmaceutical, Yaokang Biology, Ruizhi Pharmaceutical, Hainan Haiyao, Hasunlian, Haisike, and Zhaoyan New Drugs also hitting the limit up. Shutaishen, Warner Pharmaceutical Factory, Stone Pharmaceutical Innovation, and Changshan Pharmaceutical Industry have also risen by more than 10%.

Latest

3 m ago

The Bank of Japan announced the minutes of the 2016 "negative interest rate" meeting: A narrow victory of 5:4 reveals extreme internal divisions, a repeat of history ten years later?

3 m ago

Hong Kong stock market anomaly | WH Group (02714.HK) rises more than 4% as pork prices rebound by 20% in half a month, company continues to optimize costs.

5 m ago

NIO has become a strategic investor in Changxin Technology with a committed subscription amount of 1.58 billion yuan and a lock-up period of 18 months. Both parties will carry out strategic cooperation on existing car-level LPDDR4X and LPDDR5X products to build a stable and trustworthy strategic supply relationship. In recent years, NIO has been continuously laying out chip, intelligent driving, energy, and other underlying core technologies, and deepening strategic cooperation with key partners in the industry chain. (Securities Times)

6 m ago

Cooperation between law enforcement departments of China and the Philippines in repatriating suspected individuals involved in gambling and fraud.

6 m ago

According to two informed sources, payment company Stripe and private equity firm Advent International have jointly proposed to acquire Paypal (PYPL.O) at a price of $60.50 per share. This deal would value the payment company at over $53 billion. Sources said that the offer, which was submitted earlier this month, has received commitments for financing of around $50 billion from banks, representing a premium of around 28% over PayPal's closing price on Tuesday.

See all latest